Skip to content
healthcare.dev
Get a free key

Yorvipath

NDC 73362-101, Palopegteriparatide, injection, solution, from Ascendis Pharma, Endocrinology, Inc..

Product NDC
73362-101
Status
Listed
Labeler
Ascendis Pharma, Endocrinology, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA216490
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/73362-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PALOPEGTERIPARATIDE294 ug/.98mL

Pharmacologic classes

Parathyroid Hormone Analog [EPC]; Parathyroid Hormone [CS]

Package NDCNDC-11Package
73362-101-01733620101012 BOX in 1 CARTON (73362-101-01) / 1 SYRINGE in 1 BOX (73362-101-02) / 1 CARTRIDGE in 1 SYRINGE (73362-101-03) / .98 mL in 1 CARTRIDGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a1fa23fd-c434-443e-9a17-5750578c8602

Use it

Look up 73362-101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/73362-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 73362-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.